These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19398419

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.
    Circulation; 2007 Sep 11; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J, Kastrati A, Byrne RA, Bruskina O, Iijima R, Schulz S, Pache J, Seyfarth M, Massberg S, Laugwitz KL, Dirschinger J, Schömig A, LEFT-MAIN Intracoronary Stenting and Angiographic Results: Drug-Eluting Stents for Unprotected Coronary Left Main Lesions Study Investigators.
    J Am Coll Cardiol; 2009 May 12; 53(19):1760-8. PubMed ID: 19422982
    [Abstract] [Full Text] [Related]

  • 26. Percutaneous coronary intervention with stenting of left main coronary artery with drug-eluting stent in the setting of acute ST elevation myocardial infarction.
    Tan CH, Hong MK, Lee CW, Kim YH, Lee CH, Park SW, Park SJ.
    Int J Cardiol; 2008 May 23; 126(2):224-8. PubMed ID: 17493695
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA, Douglas JS, Morris DC, Block PC, Ghazzal Z, Rab ST, Cates CU.
    J Thorac Cardiovasc Surg; 2006 May 23; 131(5):956-62. PubMed ID: 16678575
    [Abstract] [Full Text] [Related]

  • 29. Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation.
    Tanaka N, Terashima M, Kinoshita Y, Kimura M, Nasu K, Ehara M, Tsuchikane E, Matsubara T, Asakura Y, Katoh O, Suzuki T.
    J Invasive Cardiol; 2008 Oct 23; 20(10):505-10. PubMed ID: 18829993
    [Abstract] [Full Text] [Related]

  • 30. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen J, Venema AC, Serruys PW, Bogers AJ.
    Eur Heart J; 2005 Apr 23; 26(7):675-81. PubMed ID: 15637087
    [Abstract] [Full Text] [Related]

  • 31. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S, Shimokawa T, Fukui T, Fumimoto KU, Ozawa N, Seki H, Takanashi S.
    J Card Surg; 2009 Apr 23; 24(3):234-9. PubMed ID: 19438773
    [Abstract] [Full Text] [Related]

  • 32. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, Hu J, Zhang Q, Ding FH.
    J Interv Cardiol; 2007 Feb 23; 20(1):10-6. PubMed ID: 17300391
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions.
    Ge L, Cosgrave J, Iakovou I, Qian JY, Agostoni P, Sangiorgi GM, Airoldi F, Michev I, Chieffo A, Corvaja N, Colombo A, Ge JB.
    Chin Med J (Engl); 2007 Apr 05; 120(7):545-51. PubMed ID: 17442200
    [Abstract] [Full Text] [Related]

  • 34. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W, European Society of Cardiology.
    Eur Heart J; 2005 Jun 05; 26(12):1169-79. PubMed ID: 15802360
    [Abstract] [Full Text] [Related]

  • 35. Temporal trends in baseline characteristics and peri-procedural complications of percutaneous drug-eluting stent implantation for unprotected left main disease: a single high-volume center experience.
    Sheiban C, Moretti C, La Spina C, Sillano D, Garrone P, Lombardi P, Sciuto F, Omedè P, Biondi-Zoccai G, Trevi GP.
    Minerva Cardioangiol; 2008 Aug 05; 56(4):381-6. PubMed ID: 18614981
    [Abstract] [Full Text] [Related]

  • 36. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 37. Hybrid coronary revascularization in the era of drug-eluting stents.
    Murphy GJ, Bryan AJ, Angelini GD.
    Ann Thorac Surg; 2004 Nov 10; 78(5):1861-7. PubMed ID: 15511503
    [Abstract] [Full Text] [Related]

  • 38. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
    Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA, Van der Giessen WJ, De Feyter P, de Jaegere P, Van Domburg RT, Serruys PW.
    Am Heart J; 2006 Nov 10; 152(5):896-902. PubMed ID: 17070153
    [Abstract] [Full Text] [Related]

  • 39. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ, Chieffo A, Magni V, Mehran R, Colombo A, Moses JW.
    Minerva Cardioangiol; 2008 Feb 10; 56(1):43-53. PubMed ID: 18432168
    [Abstract] [Full Text] [Related]

  • 40. Early and mid-term results of drug-eluting stent implantation in unprotected left main.
    Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M, Vitrella G, Colombo A.
    Circulation; 2005 Feb 15; 111(6):791-5. PubMed ID: 15699254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.